Today’s Hot List: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Lee Enterprises, Incorporated (NYSE:LEE), Western Alliance Bancorporation (NYSE:WAL), AptarGroup, Inc.

On 25 February, Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) announced its financial results for the three- and twelve-month periods ended December 31, 2015. Net income was $1.2 million, or $0.08 per basic and $0.07 per diluted share, compared to a net loss of $5.5 million, or $0.39 per basic and diluted share, for the three months ended December 31, 2014.

Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) belongs to Healthcare sector. Its net profit margin is -7.80% and weekly performance is -1.49%. On last trading day company shares ended up at $65.31. Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) distance from 50-day simple moving average (SMA50) is 31.78%.

On 24 February, Lee Enterprises, Incorporated (NYSE:LEE) announced that the company has repurchased an additional $10 million of its 9.5% Notes at an attractive discount with the remaining proceeds from a previously announced insurance settlement.

Lee Enterprises, Incorporated (NYSE:LEE) shares moved up 10.43% in last trading session and ended the day at $1.80. LEE Gross Margin is 95.60% and its return on assets is 3.20%. Lee Enterprises, Incorporated (NYSE:LEE) quarterly performance is 5.88%.

Western Alliance Bancorporation (NYSE:WAL)was upgraded by investment analysts at DA Davidson from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Thursday, The Fly reports.

On 03 March, Western Alliance Bancorporation (NYSE:WAL) shares moved up 2.00% and was closed at $32.06. WAL EPS growth in last 5 year was 66.20%. Western Alliance Bancorporation (NYSE:WAL) year to date (YTD) performance is -10.60%.

On 29 February, AptarGroup, Inc. (NYSE:ATR) announced it has completed the acquisition of Mega Airless, after receiving the necessary regulatory approvals. As previously reported, this strategic acquisition adds complementary products and market coverage to AptarGroup’s existing diversified portfolio of business.

AptarGroup, Inc. (NYSE:ATR) ended the last trading day at $75.20. Company weekly volatility is calculated as 1.86% and price to cash ratio as 9.09. AptarGroup, Inc. (NYSE:ATR) showed a weekly performance of 1.16%.

On 1 March, Smith & Nephew plc (NYSE:SNN) said that, it is showcasing the new REDAPT™ Revision Acetabular Fully Porous Cup with CONCELOC™ Technology at this week’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in Orlando.

Smith & Nephew plc (NYSE:SNN) shares fell -0.93% in last trading session and ended the day at $32.99. SNN Gross Margin is 75.30% and its return on assets is 9.20%. Smith & Nephew plc (NYSE:SNN) quarterly performance is -3.37%.

Leave a Reply

Your email address will not be published. Required fields are marked *